Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000146049 | SCV000193204 | pathogenic | Bilateral frontoparietal polymicrogyria | 2014-02-17 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV000146049 | SCV001443038 | likely pathogenic | Bilateral frontoparietal polymicrogyria | 2020-03-01 | criteria provided, single submitter | clinical testing | Review of the variants reported in Reuter et al., 2017, PMID: 28097321: PVS1_Strong,PM2,PM3_Supporting |
Labcorp Genetics |
RCV001857509 | SCV002272717 | likely pathogenic | not provided | 2021-06-19 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has been observed in individual(s) with polymicrogyria (PMID: 28097321). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 158627). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Trp657*) in the ADGRG1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 37 amino acid(s) of the ADGRG1 protein. |